Research / LYB / Fundamental state Inspectable configuration
State dimensions Filing 0001489393-22-000037 General Corporate
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.65% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.98% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
28.45% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
35.01% · OPTIONAL · VALID
Operating margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.71% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.22% · OPTIONAL · VALID
SBC intensity 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.13% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 3.47%
Current 3.65%
Delta 0.18% Cash Generation Decreased
Previous 11.70%
Current 10.98%
Delta -0.71% Growth Decreased
Previous 45.07%
Current 28.45%
Delta -16.61% Inventory Pressure Decreased
Previous 38.78%
Current 35.01%
Delta -3.77% Profitability Increased
Previous 12.94%
Current 14.71%
Delta 1.77% R And D Intensity Decreased
Previous 0.25%
Current 0.22%
Delta -0.03% Sbc Intensity Decreased
Previous 0.14%
Current 0.13%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.